Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature|October 9, 2024
Dendritic, delayed, stochastic CaMKII activation in behavioural time scale plasticityAnant Jain, Yoshihisa Nakahata, Tristano Pancani, et al.Neurobiology of Aging|April 3, 2013
Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 ratsTristano Pancani, Katie L Anderson, Lawrence D Brewer, et al.Nature Communications|March 14, 2023
Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington's disease model miceTristano Pancani, Michelle Day, Tatiana Tkatch, et al.Plos One|May 11, 2010
Effects of long-term pioglitazone treatment on peripheral and central markers of agingEric M Blalock, Jeremiah T Phelps, Tristano Pancani, et al.Journal of Alzheimer'S Disease : JAD|April 13, 2012
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseJames L Searcy, Jeremiah T Phelps, Tristano Pancani, et al.Neuron|December 22, 2017
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic ReceptorMark S Moehle, Tristano Pancani, Nellie Byun, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 miceTristano Pancani, Daniel J Foster, Mark S Moehle, et al.ACS Chemical Neuroscience|November 23, 2012
Targeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169James C Tarr, Mark L Turlington, Paul R Reid, et al.Pageof 2